N-(4-tert-Butoxyphenyl)acetamide

CAS : 2109-73-1

Ref. 3D-CAA10973

Informations sur le produit

• Nom: N-(4-tert-Butoxyphenyl)acetamide
• Synonymes: 2-Methyl-2-(4-acetaminophenoxy)propane, 4'-tert-Butoxyacetanilide, Acetamide, N-(4-(1,1-dimethylethoxy)phenyl, Acetanilide, 4′-tert-butoxy-, Bw 63-90, N-(4-tert-butoxyphenyl)acetamide, N-[4-(1,1-Dimethylethoxy)phenyl]acetamide, NSC 106564, Tromal

Description

N-(4-tert-Butoxyphenyl)acetamide (BTA) is a diagnostic agent that can be used to diagnosis autoimmune diseases, such as rheumatoid arthritis. It has been shown to bind to the CB2 receptor, which is found on cells of the immune system. BTA has also been shown to have an anti-inflammatory effect and to inhibit angiogenesis, which is the formation of new blood vessels from pre-existing vessels. This agent can be used in the treatment of leukemic mice by inhibiting hematopoietic cells. BTA may also inhibit radiation-induced tissue damage in mammalian tissue by binding fatty acids. This agent may also inhibit leukemia inhibitory factor (LIF), which has been shown to induce leukemia in mice and humans.

• Marque: Biosynth

Propriétés chimiques

• Masse moléculaire: 207.27 g/mol
• Formule: C₁₂H₁₇NO₂
• Degré de pureté: Min. 95%